Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Costing combination antiretroviral therapy for HIV infection

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Costing combination antiretroviral therapy for HIV infection. Pharmacoecon. Outcomes News 75, 4 (1996). https://doi.org/10.1007/BF03292916

    Download citation

    Keywords

    • Incremental Cost
    • Therapeutic Drug Monitoring
    • Economic Perspective
    • Pharmacoeconomic Analysis
    • Healthcare Intervention